Montreal-based Knight Therapeutics has galloped in with CAD $120 million ($84 million) to pick up Endo’s Paladin Pharma unit ...

Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-US) specialty pharmaceutical company, announced today that it has entered into a definitive Asset Purchase Agreement (“APA”) with ...

Knight will pay $120-million cash to seller Endo Operations as well as future contingency payments of up to US$15-million ...

USA-based Endo Inc (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its international ...

Knight Therapeutics has agreed to acquire generics and specialty branded pharmaceutical company Paladin Pharma for 120 million Canadian dollars ($83.1 million).

Through a clear blue sky, 3rd Infantry Division units rained steel and explosives on Fort Stewart’s impact area earlier this ...

Nippon Ichi Software has announced five new projects, due out for PlayStation and Switch platforms in 2025 and 2026 in Japan. The dungeon RPG Curse, side-scrolling action game Gobble, and horror ...

Escalating Security Threats: Healthcare facilities face rising workplace violence, cyberattacks targeting patient data, and ...

Lotus Africa Limited has assured people of Chitipa of environmental safety during activities at Kayelekera Uranium Mine in ...

Significantly high institutional ownership implies Paladin Energy's stock price is sensitive to their trading actions. 50% of the business is held by the top 8 share ...